Developing a nanotechnology-enabled glaucoma device

VisiPlate is designed to treat open-angle glaucoma
VisiPlate is an investigational implant designed to lower intraocular pressure in patients with open-angle glaucoma
Avisi in the news

Avisi Technologies Presents Positive Six-Month Clinical Data for VisiPlate® Aqueous Shunt at the American Glaucoma Society
REDWOOD CITY, Calif., April 2, 2025 /PRNewswire/ — Avisi Technologies, a clinical-stage ophthalmic device company, today announced encouraging six‐month interim results from the VITA trial evaluating its VisiPlate® device, an ultrathin, multichannel aqueous shunt in study subjects diagnosed with open-angle glaucoma. Data were presented by Eydie Miller-Ellis, MD, as a Top Paper at the American […]

Avisi Technologies Thought Leadership Impact at LSI US ’25
Recap of Avisi CEO’s Participation in Two Impactful Panels at LSI Emerging Medtech Summit Avisi Technologies returns to the Life Science Intelligence (LSI) stage with CEO Rui Jing Jiang participating in several panel discussions at the 2025 MedTech Summit. The panel discussions involved leadership and design strategies for achieving success within the MedTech industry. Life […]

Ultrathin Shunt Shows Promising Results in Trial
In an article by Glaucoma Physician, Jim Gallagher reports on the positive six-month results for VisiPlate® from the VITA trial presented by Dr. Eydie Miller-Ellis at the American Glaucoma Society (AGS). This was considered a top paper by the society and presented during the Surgery Day Paper Presentation at AGS. Dr. Miller-Ellis serves as the […]